Suchbegriffe: TEMOZOLOMIDE - , . Treffer: 2
Hoffermann, M; Bruckmann, L; Kariem Mahdy, A; Asslaber, M; Payer, F; von Campe, G
Treatment results and outcome in elderly patients with glioblastoma multiforme--a retrospective single institution analysis.
Clin Neurol Neurosurg. 2015; 128(2):60-69
Doi: 10.1016/j.clineuro.2014.11.006
Web of Science
PubMed
FullText
FullText_MUG
Spieth, K; Kaufmann, R; Dummer, R; Garbe, C; Becker, JC; Hauschild, A; Tilgen, W; Ugurel, S; Beyeler, M; Bröcker, EB; Kaehler, KC; Pföhler, C; Gille, J; Leiter, U; Schadendorf, D
Temozolomide plus pegylated interferon alfa-2b as first-line treatment for stage IV melanoma: a multicenter phase II trial of the Dermatologic Cooperative Oncology Group (DeCOG).
Ann Oncol. 2008; 19(4):801-806
Doi: 10.1093/annonc/mdm565
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar